Indeed, data we report herein, including our observations that GKT-137831 can reduce CCN2 and α-SMA expression and collagen gel contraction in SSc fibroblasts, suggest that future experiments aimed at assessing whether antioxidants or NOX inhibitors could be used to suppress the fibrotic phenotype are justified. Here, CCN2 is linked to systemic sclerosis.